Maintenance medication for healed erosive esophagitis
Part of Digestive system clinical trials.
This trial tests a new medication to keep erosive esophagitis from coming back after it has healed. If you have healed erosive esophagitis, this treatment may help prevent symptoms and damage from returning.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 19 and 75 years old
- You had erosive esophagitis that has now healed (confirmed by endoscopy)
- You do not have active heartburn or acid regurgitation in the past week
- You have not had surgery on your stomach or esophagus
- You are not currently taking certain medications for acid reflux or pain (like PPIs, H2 blockers, or NSAIDs)
- You are able to undergo an upper endoscopy and are not pregnant or breastfeeding
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new medicine (JP-1366) to see if it can keep the esophagus healed in people who have been treated for erosive esophagitis. You may join if you are an adult with healed erosive esophagitis and have taken standard acid-blocking medication for at least 4 weeks.
This study tests a new topical treatment for people with chronic heartburn and acid regurgitation who don't have erosions (damage) in their esophagus. The treatment is applied directly to the affected area and may help relieve symptoms without taking daily pills.
This trial tests an intervention meant to improve how well adults with eosinophilic esophagitis (EoE) follow their ongoing treatment plan. It may help you stay on your medicine and get better symptom control by making adherence easier.
This trial tests two medications, esomeprazole and sucralfate, to see if they help heal stomach ulcers after an endoscopic procedure (ESD) for early stomach cancer or pre-cancerous growths. It may help you if you need this procedure and have a larger ulcer afterwards.
This Phase 1/2 study tests EP-104GI in adults with eosinophilic esophagitis (EoE), a condition where certain immune cells cause inflammation in the food pipe. It may help improve symptoms and inflammation, and the study also includes a part where people who do well can switch to the active drug.
This trial tests a new medication (DWP14012) for people with stomach (gastric) ulcers. It aims to see if the drug helps ulcers heal better than a placebo.
Hear when a new Healed Erosive Esophagitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.